WallStreetZenWallStreetZen

NASDAQ: DRS
Leonardo Drs Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Leonardo Drs earnings were $250.0M for the trailing 12 months ending Jun 30, 2025, with 33.8% growth year over year. The latest DRS earnings report on Jun 30, 2025 announced Q2 2025 earnings of $54.0M, up 8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DRS reported annual earnings of $213.0M, with 26.8% growth. The next DRS earnings date is Oct 29, 2025.

DRS past earnings growth

How has DRS's earnings growth performed historically?

Company
33.8%
Industry
42.48%
Market
29.29%
DRS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DRS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DRS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DRS earnings history

Current Revenue
$3.4B
Current Earnings
$250.0M
Current Profit Margin
7.3%

DRS Return on Equity

Current Company
9.8%
Current Industry
13.2%
Current Market
32.2%
DRS's Return on Equity (9.8%)... subscribe to Premium to read more.
High Return on Equity Performance

DRS undefined

Current Company
6.2%
Current Industry
3.3%
DRS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DRS announces earnings.

DRS undefined

Current Company
10.16%
Current Industry
6.1%
DRS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DRS vs Defense Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DRS$409.00M$250.00M+9.53%$0.95
AVAV$97.85M$43.62M-2.05%$1.56
HII$1.05B$525.00M+0.75%$13.36
KTOS$82.00M$19.50M+7.63%$0.13
ERJ$1.21B$352.50M+118.18%$1.92
View Top Defense Stocks

DRS earnings dates

Next earnings date
Oct 29, 2025

Leonardo Drs Earnings Reports & History FAQ

What were Leonardo Drs's earnings last quarter?

On DRS's earnings call on Invalid Date, Leonardo Drs (NASDAQ: DRS) reported Q2 2025 earnings per share (EPS) of $0.20, up 42.86% year over year. Total DRS earnings for the quarter were $54.00 million. In the same quarter last year, Leonardo Drs's earnings per share (EPS) was $0.14.

If you're new to stock investing, here's how to buy Leonardo Drs stock.

When does Leonardo Drs report earnings?

The next DRS earnings call is Invalid Date. Add DRS to your watchlist to be reminded of Leonardo Drs's next earnings date.

Is Leonardo Drs profitable or losing money?

As of the last Leonardo Drs earnings report, Leonardo Drs is currently profitable. Leonardo Drs's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $250.00 million, a 32.98% increase year over year.

What was DRS's earnings growth in the past year?

As of Leonardo Drs's earnings date in Invalid Date, Leonardo Drs's earnings has grown 33.8% year over year. This is 8.68 percentage points lower than the US Aerospace & Defense industry earnings growth rate of 42.48%. DRS earnings in the past year totalled $250.00 million.

What are Leonardo Drs's earnings expectations?

The current EPS estimate for Leonardo Drs's earnings report in Invalid Date is $0.00.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.